Tuberculosis and Respiratory Diseases

Original Article

COPD, Asthma

Association of Nutritional Intake with Physical Activity and Handgrip Strength in Individuals with Airflow Limitation

I Re Heo, Tae Hoon Kim, Jong Hwan Jeong, et al.

Tuberc Respir Dis. 2025;88(1):120-129. Published online October 11, 2024

Background: We investigated whether nutritional intake is associated with physical activity (PA) and handgrip strength (HGS) in individuals with airflow limitation. Methods: This study analyzed data from the 2014 and 2016 Korean National Health and Nutrition Examination Survey. We assessed total protein intake (g/day), caloric intake (kcal/day), and other nutritional intakes, using a 24-hour dietary recall questionnaire. HGS was measured three...

DOI: https://doi.org/10.4046/trd.2024.0017

Original Article

Interstitial Lung Disease

Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures

Hyeon Kyu Choi, Gaeul Bang, Ju Hye Shin, et al.

Tuberc Respir Dis. 2025;88(1):130-137. Published online September 27, 2024

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease that culminates in respiratory failure and death due to irreversible scarring of the distal lung. While initially considered a chronic inflammatory disorder, the aberrant function of the alveolar epithelium is now acknowledged as playing a central role in the pathophysiology of IPF. This study aimed to investigate the regenerative...

DOI: https://doi.org/10.4046/trd.2024.0094

Original Article

Lung Cancer

KEAP1-NRF2 Pathway as a Novel Therapeutic Target for EGFR-Mutant Non-small Cell Lung Cancer

Jae-Sun Choi, Hye-Min Kang, Kiyong Na, et al.

Tuberc Respir Dis. 2025;88(1):138-149. Published online September 23, 2024

Cited By 1

Background: Kelch-like ECH-associated protein 1 (KEAP1)–nuclear factor erythroid- 2-related factor 2 (NRF2) pathway is a major regulator protecting cells from oxidative and metabolic stress. Studies have revealed that this pathway is involved in mediating resistance to cytotoxic chemotherapy and immunotherapy; however, its implications in oncogene-addicted tumors are largely unknown. This study aimed to elucidate whether this pathway could be a...

DOI: https://doi.org/10.4046/trd.2024.0087

Original Article

Tuberculosis

Diagnostic Accuracy of BD MAX MDR-TB Assay Performed on Bronchoscopy Specimens in Patients with Suspected Pulmonary Tuberculosis

Sung Jun Ko, Kui Hyun Yoon

Tuberc Respir Dis. 2025;88(1):150-158. Published online September 23, 2024

Background: Several novel molecular platforms using nucleic acid amplification tests have been developed for the diagnosis of pulmonary tuberculosis (PTB) and rapid detection of isoniazid and rifampin resistance. Among them, the BD MAX MDR-TB assay (BD MAX) has shown high sensitivity and specificity; however, its diagnostic accuracy performed on bronchoscopy specimens has not been reported. Methods: We retrospectively reviewed the medical...

DOI: https://doi.org/10.4046/trd.2024.0091

Original Article

Tuberculosis

Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study

Jinsoo Min, Yousang Ko, Hyung Woo Kim, et al.

Tuberc Respir Dis. 2025;88(1):159-169. Published online September 23, 2024

Background: This study aimed to identify the clinical characteristics of multidrug-resistant/ rifampicin-resistant tuberculosis (MDR/RR-TB) in the Republic of Korea. Methods: Data of notified people with tuberculosis between July 2018 and December 2021 were retrieved from the Korea Tuberculosis Cohort database. MDR/RR-TB was further categorized according to isoniazid susceptibility as follows: multidrug-resistant tuberculosis (MDR-TB), rifampicin-monoresistant tuberculosis (RMR-TB), and RR-TB if susceptibility to...

DOI: https://doi.org/10.4046/trd.2024.0049

Original Article

Tuberculosis

High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis

Nakwon Kwak, Joong-Yub Kim, Hyung-Jun Kim, et al.

Tuberc Respir Dis. 2025;88(1):170-180. Published online September 27, 2024

Background: This study aimed to determine whether a shorter high-dose rifampicin regimen is non-inferior to the standard 6-month tuberculosis regimen. Methods: This multicenter, randomized, open-label, non-inferiority trial enrolled participants with respiratory specimen positivity by Xpert MTB/RIF assay or Mycobacterium tuberculosis culture without rifampicin-resistance. Participants were randomized at 1:1 to the investigational or control group. The investigational group received high-dose rifampicin (30...

DOI: https://doi.org/10.4046/trd.2024.0099

Original Article

Miscellaneous, Pleural Diseases

Dry Medical Thoracoscopy with Artificial Pneumothorax Induction Using Veress Needle

Nai-Chien Huan, Sze Shyang Kho, Larry Ellee Nyanti, et al.

Tuberc Respir Dis. 2025;88(1):181-189. Published online November 14, 2024

Background: In the absence of significant pleural effusion, conventional medical thoracoscopy (MT) is often not feasible due to the risk of lung injury. Dry MT mitigates these risks by inducing artificial pneumothorax through needle insufflation or blunt dissection. Although the Veress needle is commonly used by surgeons to create pneumoperitoneum before laparoscopic surgeries, its application in dry MT has not...

DOI: https://doi.org/10.4046/trd.2024.0029

Current Issue: Volume 88(1); Jan 2025

This archive contains links to the full-text of all issues of Tuberc Respir Dis.

Current issue

Volume 88(1); January

All issues

Vol. 88
2025

v.88(1)
Jan 2025

Vol. 87
2024

v.87(1)
Jan 2024

v.87(2)
Apr 2024

v.87(3)
Jul 2024

v.87(4)
Oct 2024

Vol. 86
2023

v.86(1)
Jan 2023

v.86(2)
Apr 2023

v.86(3)
Jul 2023

v.86(4)
Oct 2023

Vol. 85
2022

v.85(1)
Jan 2022

v.85(2)
Apr 2022

v.85(3)
Jul 2022

v.85(4)
Oct 2022

Vol. 84
2021

v.84(1)
Jan 2021

v.84(2)
Apr 2021

v.84(3)
Jul 2021

v.84(4)
Oct 2021

Vol. 83
2020

v.83(1)
Jan 2020

v.83(2)
Apr 2020

v.83(3)
Jul 2020

v.83(4)
Oct 2020

v.83(Supple 1)
Dec 2020

Vol. 82
2019

v.82(1)
Jan 2019

v.82(2)
Apr 2019

v.82(3)
Jul 2019

v.82(4)
Oct 2019

Vol. 81
2018

v.81(1)
Jan 2018

v.81(2)
Apr 2018

v.81(3)
Jul 2018

v.81(4)
Oct 2018

Vol. 80
2017

v.80(1)
Jan 2017

v.80(2)
Apr 2017

v.80(3)
Jul 2017

v.80(4)
Oct 2017

Vol. 79
2016

v.79(1)
Jan 2016

v.79(2)
Apr 2016

v.79(3)
Jul 2016

v.79(4)
Oct 2016

Vol. 78
2015

v.78(1)
Jan 2015

v.78(2)
Apr 2015

v.78(3)
Jul 2015

v.78(4)
Oct 2015

Vol. 77
2014

v.77(1)
Jul 2014

v.77(2)
Aug 2014

v.77(3)
Sep 2014

v.77(4)
Oct 2014

v.77(5)
Nov 2014

v.77(6)
Dec 2014

Vol. 76
2014

v.76(1)
Jan 2014

v.76(2)
Feb 2014

v.76(3)
Mar 2014

v.76(4)
Apr 2014

v.76(5)
May 2014

v.76(6)
Jun 2014

Vol. 75
2013

v.75(1)
Jul 2013

v.75(2)
Aug 2013

v.75(3)
Sep 2013

v.75(4)
Oct 2013

v.75(5)
Nov 2013

v.75(6)
Dec 2013

Vol. 74
2013

v.74(1)
Jan 2013

v.74(2)
Feb 2013

v.74(3)
Mar 2013

v.74(4)
Apr 2013

v.74(5)
May 2013

v.74(6)
Jun 2013

Vol. 73
2012

v.73(1)
Jul 2012

v.73(2)
Aug 2012

v.73(3)
Sep 2012

v.73(4)
Oct 2012

v.73(5)
Nov 2012

v.73(6)
Dec 2012

Vol. 72
2012

v.72(1)
Jan 2012

v.72(2)
Feb 2012

v.72(3)
Mar 2012

v.72(4)
Apr 2012

v.72(5)
May 2012

v.72(6)
Jun 2012

Vol. 71
2011

v.71(1)
Jul 2011

v.71(2)
Aug 2011

v.71(3)
Sep 2011

v.71(4)
Oct 2011

v.71(5)
Nov 2011

v.71(6)
Dec 2011

Vol. 70
2011

v.70(1)
Jan 2011

v.70(2)
Feb 2011

v.70(3)
Mar 2011

v.70(4)
Apr 2011

v.70(5)
May 2011

v.70(6)
Jun 2011

Vol. 69
2010

v.69(1)
Jul 2010

v.69(2)
Aug 2010

v.69(3)
Sep 2010

v.69(4)
Oct 2010

v.69(5)
Nov 2010

v.69(6)
Dec 2010

Vol. 68
2010

v.68(1)
Jan 2010

v.68(2)
Feb 2010

v.68(3)
Mar 2010

v.68(4)
Apr 2010

v.68(5)
May 2010

v.68(6)
Jun 2010

Vol. 67
2009

v.67(1)
Jul 2009

v.67(2)
Aug 2009

v.67(3)
Sep 2009

v.67(4)
Oct 2009

v.67(5)
Nov 2009

v.67(6)
Dec 2009

Vol. 66
2009

v.66(1)
Jan 2009

v.66(2)
Feb 2009

v.66(3)
Mar 2009

v.66(4)
Apr 2009

v.66(5)
May 2009

v.66(6)
Jun 2009

Vol. 65
2008

v.65(1)
Jul 2008

v.65(2)
Aug 2008

v.65(3)
Sep 2008

v.65(4)
Oct 2008

v.65(5)
Nov 2008

v.65(6)
Dec 2008

Vol. 64
2008

v.64(1)
Jan 2008

v.64(2)
Feb 2008

v.64(3)
Mar 2008

v.64(4)
Apr 2008

v.64(5)
May 2008

v.64(6)
Jun 2008

Vol. 63
2007

v.63(1)
Jul 2007

v.63(2)
Aug 2007

v.63(3)
Sep 2007

v.63(4)
Oct 2007

v.63(5)
Nov 2007

v.63(6)
Dec 2007

Vol. 62
2007

v.62(1)
Jan 2007

v.62(2)
Feb 2007

v.62(3)
Mar 2007

v.62(4)
Apr 2007

v.62(5)
May 2007

v.62(6)
Jun 2007

Vol. 61
2006

v.61(1)
Jul 2006

v.61(2)
Aug 2006

v.61(3)
Sep 2006

v.61(4)
Oct 2006

v.61(5)
Nov 2006

v.61(6)
Dec 2006

Vol. 60
2006

v.60(1)
Jan 2006

v.60(2)
Feb 2006

v.60(3)
Mar 2006

v.60(4)
Apr 2006

v.60(5)
May 2006

v.60(6)
Jun 2006

Vol. 59
2005

v.59(1)
Jul 2005

v.59(2)
Aug 2005

v.59(3)
Sep 2005

v.59(4)
Oct 2005

v.59(5)
Nov 2005

v.59(6)
Dec 2005

Vol. 58
2005

v.58(1)
Jan 2005

v.58(2)
Feb 2005

v.58(3)
Mar 2005

v.58(4)
Apr 2005

v.58(5)
May 2005

v.58(6)
Jun 2005

Vol. 57
2004

v.57(1)
Jul 2004

v.57(2)
Aug 2004

v.57(3)
Sep 2004

v.57(4)
Oct 2004

v.57(5)
Nov 2004

v.57(6)
Dec 2004

Tuberculosis and Respiratory Diseases1954 (v1 n1) to 2004 (v56 n6)

Vol. 56
2004

v.56(1)
Jan 2004

v.56(2)
Feb 2004

v.56(3)
Mar 2004

v.56(4)
Apr 2004

v.56(5)
May 2004

v.56(6)
Jun 2004

Vol. 55
2003

v.55(1)
Jul 2003

v.55(2)
Aug 2003

v.55(3)
Sep 2003

v.55(4)
Oct 2003

v.55(5)
Nov 2003

v.55(6)
Dec 2003

Vol. 54
2003

v.54(1)
Jan 2003

v.54(2)
Feb 2003

v.54(3)
Mar 2003

v.54(4)
Apr 2003

v.54(5)
May 2003

v.54(6)
Jun 2003

Vol. 53
2002

v.53(1)
Jul 2002

v.53(2)
Aug 2002

v.53(3)
Sep 2002

v.53(4)
Oct 2002

v.53(5)
Nov 2002

v.53(6)
Dec 2002

Vol. 52
2002

v.52(1)
Jan 2002

v.52(2)
Feb 2002

v.52(3)
Mar 2002

v.52(4)
Apr 2002

v.52(5)
May 2002

v.52(6)
Jun 2002

Vol. 51
2001

v.51(1)
Jul 2001

v.51(2)
Aug 2001

v.51(3)
Sep 2001

v.51(4)
Oct 2001

v.51(5)
Nov 2001

v.51(6)
Dec 2001

Vol. 50
2001

v.50(1)
Jan 2001

v.50(2)
Feb 2001

v.50(3)
Mar 2001

v.50(4)
Apr 2001

v.50(5)
May 2001

v.50(6)
Jun 2001

Vol. 49
2000

v.49(1)
Jul 2000

v.49(2)
Aug 2000

v.49(3)
Sep 2000

v.49(4)
Oct 2000

v.49(5)
Nov 2000

v.49(6)
Dec 2000

Vol. 48
2000

v.48(1)
Jan 2000

v.48(2)
Feb 2000

v.48(3)
Mar 2000

v.48(4)
Apr 2000

v.48(5)
May 2000

v.48(6)
Jun 2000

Vol. 47
1999

v.47(1)
Jul 1999

v.47(2)
Aug 1999

v.47(3)
Sep 1999

v.47(4)
Oct 1999

v.47(5)
Nov 1999

v.47(6)
Dec 1999

Vol. 46
1999

v.46(1)
Jan 1999

v.46(2)
Feb 1999

v.46(3)
Mar 1999

v.46(4)
Apr 1999

v.46(5)
May 1999

v.46(6)
Jun 1999

Vol. 45
1998

v.45(1)
Feb 1998

v.45(2)
Apr 1998

v.45(3)
Jun 1998

v.45(4)
Aug 1998

v.45(5)
Oct 1998

v.45(6)
Dec 1998

Vol. 44
1997

v.44(1)
Feb 1997

v.44(2)
Apr 1997

v.44(3)
Jun 1997

v.44(4)
Aug 1997

v.44(5)
Oct 1997

v.44(6)
Dec 1997

Vol. 43
1996

v.43(1)
Feb 1996

v.43(2)
Apr 1996

v.43(3)
Jun 1996

v.43(4)
Aug 1996

v.43(5)
Oct 1996

v.43(6)
Dec 1996

Vol. 42
1995

v.42(1)
Feb 1995

v.42(2)
Apr 1995

v.42(3)
Jun 1995

v.42(4)
Aug 1995

v.42(5)
Oct 1995

v.42(6)
Dec 1995

Vol. 41
1994

v.41(1)
Feb 1994

v.41(2)
Apr 1994

v.41(3)
Jun 1994

v.41(4)
Aug 1994

v.41(5)
Oct 1994

v.41(6)
Dec 1994

Vol. 40
1993

v.40(1)
Feb 1993

v.40(2)
Apr 1993

v.40(3)
Jun 1993

v.40(4)
Aug 1993

v.40(5)
Oct 1993

v.40(6)
Dec 1993

Vol. 39
1992

v.39(1)
Feb 1992

v.39(2)
Apr 1992

v.39(3)
Jun 1992

v.39(4)
Aug 1992

v.39(5)
Oct 1992

v.39(6)
Dec 1992

Vol. 38
1991

v.38(1)
Mar 1991

v.38(2)
Jun 1991

v.38(3)
Sep 1991

v.38(4)
Dec 1991

Vol. 37
1990

v.37(1)
Mar 1990

v.37(2)
Jun 1990

v.37(3)
Sep 1990

v.37(4)
Dec 1990

Vol. 36
1989

v.36(1)
Mar 1989

v.36(2)
Jun 1989

v.36(3)
Sep 1989

v.36(4)
Dec 1989

Vol. 35
1988

v.35(1)
Mar 1988

v.35(2)
Jun 1988

v.35(3)
Sep 1988

v.35(4)
Dec 1988

Vol. 34
1987

v.34(1)
Mar 1987

v.34(2)
Jun 1987

v.34(3)
Sep 1987

v.34(4)
Dec 1987

Vol. 33
1986

v.33(1)
Mar 1986

v.33(2)
Jun 1986

v.33(3)
Sep 1986

v.33(4)
Dec 1986

Vol. 32
1985

v.32(1)
Mar 1985

v.32(2)
Jun 1985

v.32(3)
Sep 1985

v.32(4)
Dec 1985

Vol. 31
1984

v.31(1)
Mar 1984

v.31(2)
Jun 1984

v.31(3)
Sep 1984

v.31(4)
Dec 1984

Vol. 30
1983

v.30(1)
Mar 1983

v.30(2)
Jun 1983

v.30(3)
Sep 1983

v.30(4)
Dec 1983

Vol. 29
1982

v.29(1)
Mar 1982

v.29(2)
Jun 1982

v.29(3)
Sep 1982

v.29(4)
Dec 1982

Vol. 28
1981

v.28(1)
Mar 1981

v.28(2)
Jun 1981

v.28(3)
Sep 1981

v.28(4)
Dec 1981

Vol. 27
1980

v.27(1)
Mar 1980

v.27(2)
Jun 1980

v.27(3)
Sep 1980

v.27(4)
Dec 1980

Vol. 26
1979

v.26(1)
Mar 1979

v.26(2)
Jun 1979

v.26(3)
Sep 1979

v.26(4)
Dec 1979

Vol. 25
1978

v.25(1)
Mar 1978

v.25(2)
Jun 1978

v.25(3)
Sep 1978

v.25(4)
Dec 1978

Vol. 24
1977

v.24(1)
Mar 1977

v.24(2)
Jun 1977

v.24(3)
Sep 1977

v.24(4)
Dec 1977

Vol. 23
1976

v.23(1)
Mar 1976

v.23(2)
Jun 1976

v.23(3)
Sep 1976

v.23(4)
Dec 1976

Vol. 22
1975

v.22(1)
Mar 1975

v.22(2)
Jun 1975

v.22(3)
Sep 1975

v.22(4)
Dec 1975

Vol. 21
1974

v.21(1)
Mar 1974

v.21(2)
Jun 1974

v.21(3)
Sep 1974

v.21(4)
Dec 1974

Vol. 20
1973

v.20(1)
Mar 1973

v.20(2)
Jun 1973

v.20(3)
Sep 1973

v.20(4)
Dec 1973

Vol. 19
1972

v.19(1)
Mar 1972

v.19(2)
Jun 1972

v.19(3)
Sep 1972

v.19(4)
Dec 1972

Vol. 18
1971

v.18(1)
Mar 1971

v.18(2)
Jun 1971

v.18(3)
Sep 1971

v.18(4)
Dec 1971

Vol. 17
1970

v.17(1)
Mar 1970

v.17(2)
Jun 1970

v.17(3)
Sep 1970

v.17(4)
Dec 1970

Vol. 16
1969

v.16(1)
Mar 1969

v.16(2)
Jun 1969

v.16(3)
Sep 1969

v.16(4)
Dec 1969

Vol. 15
1968

v.15(1)
Mar 1968

v.15(2)
Jun 1968

v.15(3)
Sep 1968

v.15(4)
Dec 1968

1967

No.26
Dec 1967

No.27
Dec 1967

No.28
Dec 1967

No.29
Dec 1967

1966

No.22
Dec 1966

No.23
Dec 1966

No.24
Dec 1966

No.25
Dec 1966

1965

No.19
Dec 1965

No.20
Dec 1965

No.21
Dec 1965

1964

No.17
Dec 1964

No.18
Dec 1964

1963

No.15
Dec 1963

No.16
Dec 1963

1962

No.12
Dec 1962

No.13
Dec 1962

No.14
Dec 1962

1961

No.10
Dec 1961

No.11
Dec 1961

1960

No.8
Dec 1960

No.9
Dec 1960

1959

No.7
Dec 1959

1958

No.5
Dec 1958

No.6
Dec 1958

1957

No.4
Dec 1957

1956

No.3
Dec 1956

1955

No.2
Dec 1955

1954

No.1
Dec 1954

31,723	Clonal Hematopoiesis of Indeterminate Potential Is Associated with Current Smoking Status and History of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
8,223	Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis
4,082	Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures
6,149	Summary of Korean Asthma Guideline
4,049	Tuberculosis Notification and Incidence: Republic of Korea, 2022

Cited By 27	Tuberculosis: Republic of Korea, 2021
Cited By 14	Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model
Cited By 12	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
Cited By 7	Low Skeletal Muscle Mass and Clinical Outcomes in Chronic Obstructive Pulmonary Disease
Cited By 7	Chronic Obstructive Pulmonary Disease and the Airway Microbiome: What Respirologists Need to Know